VIVEbiotech Launches Lentiviral Vectors Mfg. Plant
Increases production capacity by 400% to deliver commercial-size batches for Cell and Gene Therapy Sector.
Base Editor Corrects Sickle-Cell Disease Mutation, Achieves Phenotypic Rescue in Mice
An adenine base editor was used to convert the sickle-cell disease (SCD) allele to a nonpathogenic allele in hematopoietic stem and…
DNA sequencing test maker Helix doubles down on COVID-19 testing, tracking with $50M series C
DNA sequencing test maker Helix doubles down on COVID-19 testing, tracking with $50M series C…
Novartis reports 'clinically relevant' survival data for Lutathera
The radioligand therapy was linked with a significant increase in progression-free survival and a clinically relevant increase in overall survival in…
Jubilant HollisterStier Expands Sterile Injectable Mfg. Capacity
Investing $92 million at its site in Spokane, WA to add 50% capacity, which will be commercially operational by the end of 2024.
Gut Microbiome Linked to Breast Microbiome and Breast Cancer
Scientists at Wake Forest School of Medicine demonstrate that diet, including fish oil supplements, can not only alter the breast…
Organon launches ready to shop for women's health companies in biotech, medtech and more
Organon launches ready to shop for women's health companies in biotech, medtech and more…
NICE turns down GSK's IV Benlysta for systemic lupus
The cost watchdog said uncertain trial evidence and cost-effectiveness estimates are behind the preliminary decision